Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy | Zendy

Dmytro Butov | Zendy; S. L. Zaitseva | Zendy; Tetiana Butova | Zendy

Open Access

Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy

Author(s) -

Dmytro Butov,

S. L. Zaitseva,

Tetiana Butova

Publication year - 2016

Publication title -

international journal of mycobacteriology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.53

H-Index - 20

eISSN - 2212-554X

pISSN - 2212-5531

DOI - 10.1016/j.ijmyco.2016.09.046

Subject(s) - medicine , ethambutol , pyrazinamide , rifampicin , isoniazid , tuberculosis , streptomycin , antimycobacterial , chemotherapy , gastroenterology , surgery , mycobacterium tuberculosis , antibiotics , pathology , microbiology and biotechnology , biology

The aim of this work was to study the efficacy and safety of quercetin and polyvinylpyrrolidone (QP) in the treatment of patients with newly diagnosed destructive pulmonary tuberculosis (TB) in comparison with standard antimycobacterial therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research